|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 323 TWD | -1.82% |
|
+3.19% | +18.75% |
Lotus Pharmaceutical Co., Ltd. reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported sales was TWD 3,419 million. Net income was TWD 400 million.
Basic earnings per share from continuing operations was TWD 1.53.
| 1st Jan change | Capi. | |
|---|---|---|
| +18.75% | 2.62B | |
| +32.68% | 704B | |
| +27.95% | 577B | |
| -4.54% | 348B | |
| +18.17% | 327B | |
| +4.65% | 288B | |
| +14.60% | 234B | |
| +4.93% | 198B | |
| -9.78% | 194B | |
| -4.69% | 147B |
LOTUS PHARMACEUTICAL CO., LTD. 
